This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.

Accept

Immune to Cancer:
The CRI Blog

Let's spread the word about Immunotherapy! Click to share this page with your community.
Filter by:
Subscribe

Recent Posts
ovarian cancer cervical cancer patient summit series patient education gynecologic cancers uterine cancer

Ovarian Cancer and Immunotherapy

Caroline Offit
November 23, 2020
melanoma patient summit series patient education

Melanoma and Immunotherapy

Caroline Offit
November 16, 2020
prostate cancer patient summit series patient education

5 Prostate Cancer Questions Answered

CRI Staff
November 12, 2020
prostate cancer patient summit series patient education

Prostate Cancer and Immunotherapy

Caroline Offit
November 11, 2020
clinical trials patient summit series patient education

Immunotherapy Clinical Trials

Caroline Offit
November 09, 2020

*Immunotherapy results may vary from patient to patient.

CRI.ContactUs

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

800-992-2623212-832-9376Staff Directory

Stay Connected with CRI

Follow us

Recent Blog Posts

In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy for non-small cell lung cancer.

Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.
Top